ESPR Net Change in Cash
Esperion Therapeutics Inc · Net Change in Cash
ESPR Net Change in Cash
Latest reported$41.53Mperiod ending
ESPR TTM Net Change in Cash ($64.32M → $41.53M)
TTM net change in cash
High-resolution chart · PNG
ESPR net change in cash history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Net Change in Cash (USD) |
|---|---|
| 41,525,000 | |
| 23,091,000 | |
| -52,270,000 | |
| -103,243,000 | |
| -111,976,000 | |
| 62,513,000 | |
| 29,884,000 | |
| 50,834,000 | |
| 81,698,000 | |
| -42,527,000 | |
| -44,566,000 | |
| 15,530,000 | |
| -5,453,000 | |
| -84,117,000 | |
| 55,727,000 | |
| -46,246,000 | |
| -17,575,000 | |
| -46,070,000 | |
| -62,076,000 | |
| -79,303,000 | |
| 67,625,000 | |
| 137,904,000 | |
| 2,842,000 | |
| 23,217,000 | |
| -25,715,000 | |
| 130,085,000 | |
| 186,151,000 | |
| 250,892,000 | |
| 145,206,000 | |
| 2,505,000 | |
| 5,731,000 | |
| 4,007,000 | |
| 10,956,000 | |
| -3,697,000 | |
| -26,116,000 | |
| -28,395,000 | |
| -17,340,000 | |
| -39,171,000 | |
| -33,684,000 | |
| -81,019,000 | |
| -171,434,000 | |
| -7,702,000 | |
| 40,592,000 | |
| 81,843,000 | |
| 160,003,000 | |
| 28,501,000 | |
| -31,663,467 | |
| 31,317,502 | |
| 44,752,145 | |
| 50,025,840 | |
| 68,730,754 | |
| 14,577,180 | |
| -993,195 | |
| 4,940,437 | |
| 38,072,990 | |
| 33,558,595 | |
| 27,494,327 | |
| 23,299,000 | |
| -17,472,000 | |
| -32,318,000 | |
| -29,787,000 | |
| -35,599,000 | |
| -8,009,000 | |
| -738,000 | |
| 58,000 | |
| 1,347,000 | |
| 31,002,000 | |
| 36,962,932 | |
| 64,324,068 |